The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,494,206 in first-year total cost, median $135,998.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-1 (M1)]11
Most frequent institutions
- UNIVERSITY OF TX MD ANDERSON CAN CTR2
- BAYLOR COLLEGE OF MEDICINE1
- CLEVELAND CLINIC LERNER COM-CWRU1
- DUKE UNIVERSITY1
- HARVARD MEDICAL SCHOOL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | High dimensional digital pathology to investigate the tumor micro environment and its impact on response to therapy1R50CA252138-01 | MALIGA, ZOLTAN | HARVARD MEDICAL SCHOOL, MA | $215,543 | ZCA1 |
| 2020 | Systems analysis of the prostate cancer epigenome1R50CA251843-01 | CHEN, ZHONG | DUKE UNIVERSITY, NC | $198,304 | ZCA1 |
| 2020 | Translational science specialist in genitourinary cancers1R50CA251961-01 | BERK, MICHAEL P. | CLEVELAND CLINIC LERNER COM-CWRU, OH | $165,535 | ZCA1 |
| 2020 | Functional Genomics of High Grade Glioma1R50CA252125-01 | YU, KWANHA | BAYLOR COLLEGE OF MEDICINE, TX | $152,274 | ZCA1 |
| 2020 | Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response1R50CA251960-01 | PARSELS, LESLIE ANNE | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $143,779 | ZCA1 |
| 2020 | The Functional Role of GRM3 in Colon Cancer1R50CA243898-01A1 | GENG, LIYING | OHIO STATE UNIVERSITY, OH | $135,998 | ZCA1 |
| 2020 | Modeling tumor heterogeneity and treatment resistance in small cell lung cancer1R50CA243698-01A1 | STEWART, CATHERINE ALLISON | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $116,847 | ZCA1 |
| 2020 | Development and Characterization of Immunotherapies for HPV-Associated Malignancies1R50CA251953-01 | PENG, SHIWEN | JOHNS HOPKINS UNIVERSITY, MD | $97,926 | ZCA1 |
| 2020 | Single cell analysis of the evolving mutational landscape in carcinogen exposed skin1R50CA251479-01 | KANDYBA, EVE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $97,205 | ZCA1 |
| 2020 | Mechanisms of Drug Resistance in Acute Myeloid Leukemia1R50CA251708-01 | NECHIPORUK, TAMILLA | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $87,133 | ZCA1 |
| 2020 | Identifying the vulnerabilities in Mdm2 overexpressing cancer cells1R50CA251703-01 | PANT, VINOD | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $83,662 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.